Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pancreatic Uptake on 99mTc-MIBI and 99mTc-Tetrofosmin Myocardial Perfusion SPECT/CT.

Clinical nuclear medicine·2026

Same author

Quantitative agreement between AMYclz and CortexID for <sup>18</sup>F-florbetapir amyloid PET: a retrospective study of 103 patients.

Japanese journal of radiology·2026

Same author

Graph-Enhanced Expectation Maximization for Emission Tomography.

Journal of imaging·2026

Same author

Quantitative indices from post-PRRT SPECT/CT: an exploratory approach to early imaging biomarkers in neuroendocrine tumors.

Japanese journal of radiology·2026

Same author

Feasibility study of unsupervised anomaly detection using Wasserstein GAN in SPECT image.

EJNMMI physics·2025

Same author

Comparative evaluation of CortexID and VIZCalc software in brain amyloid PET: a retrospective study of 116 cases.

Annals of nuclear medicine·2025

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

FDG-PET/CT for cancer management.

Hideki Otsuka¹, Naomi Morita, Kyo Yamashita

¹Department of Radiology, Institute of Health Biosciences, The University of Tokushima, Graduate School, Tokushima, Japan.

The Journal of Medical Investigation : JMI

|September 20, 2007

Summary

Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) aids cancer staging and monitoring. Understanding its use and limitations improves patient care through accurate diagnosis.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing ¹⁸F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)

Published on: May 2, 2012

Related Experiment Videos

Last Updated: Jul 11, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing ¹⁸F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)

Published on: May 2, 2012

Area of Science:

Oncology
Nuclear Medicine
Radiology

Background:

FDG-PET/CT is a vital imaging tool in modern oncology.
It combines anatomical and functional information in a single examination.

Observation:

The technique utilizes fluorodeoxyglucose (FDG) to visualize metabolic activity.
PET/CT systems integrate Positron Emission Tomography (PET) and Computed Tomography (CT) imaging.

Findings:

FDG-PET/CT is increasingly adopted for cancer staging, restaging, and treatment response assessment.
Knowledge of normal FDG distribution is crucial for accurate interpretation.

Implications:

Understanding the indications and limitations of FDG-PET/CT enhances diagnostic accuracy.
Improved diagnostic capabilities lead to better patient management and outcomes in cancer care.